Neochem Bio Solutions Ratios

Neochem Bio Solutions Ltd Ratios

The Neochem Bio Solutions Ltd Ratios page provides a complete fundamental analysis of Neochem Bio Solutions Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Neochem Bio Solutions Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Neochem Bio Solutions Ltd (NSE: NEOCHEM, BSE: 95754) is currently trading at ₹63.25, with a market capitalization of ₹1.17B. As a major player in the Process industries sector and Chemicals: major diversified industry, Neochem Bio Solutions Ltd remains a key stock for fundamental analysis using Neochem Bio Solutions Ltd Ratios.

Neochem Bio Solutions Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Neochem Bio Solutions Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Neochem Bio Solutions Ltd Ratios.

Historically, the Neochem Bio Solutions Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0

The decline in Neochem Bio Solutions Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Neochem Bio Solutions Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0

Neochem Bio Solutions Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Neochem Bio Solutions Ltd P/S ratio currently stands at 0, an important part of Neochem Bio Solutions Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0

A stable or declining Neochem Bio Solutions Ltd P/S ratio indicates cautious market sentiment.

Neochem Bio Solutions Ltd Price to Cash Flow Ratio (P/CF)

The Neochem Bio Solutions Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Neochem Bio Solutions Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0

The declining Neochem Bio Solutions Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Neochem Bio Solutions Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Neochem Bio Solutions Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0

Neochem Bio Solutions Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Neochem Bio Solutions Ltd EV/EBITDA ratio is currently 0, a key metric in Neochem Bio Solutions Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0

Stable Neochem Bio Solutions Ltd EV/EBITDA indicates balanced valuation.

Neochem Bio Solutions Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Neochem Bio Solutions Ltd D/E ratio is currently 1.80, reflecting leverage and financial stability.

Historical D/E:

• 2024: 1.80
• 2023: 2.78
• 2022: 3.26

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Neochem Bio Solutions Ltd ROE currently stands at 48.82%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 48.82
• 2023: 17.96
• 2022: 0

Neochem Bio Solutions Ltd demonstrates strong profitability and efficient capital utilization.

Neochem Bio Solutions Ltd Ratios Analysis Summary

The Neochem Bio Solutions Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Neochem Bio Solutions Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Neochem Bio Solutions Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.